Please login to the form below

Not currently logged in
Email:
Password:

Kirsti Gjellan swaps Pfizer for Sobi

Takes up role as senior VP manufacturing operations at Swedish Orphan Biovitrum

Sobi Kirsti GjellanSwedish Orphan Biovitrum (Sobi) has appointed Pfizer's Kirsti Gjellan as senior VP manufacturing operations.

Sobi gains an experienced mind with Gjellan, who most recently serving as managing director for Pfizer in Sweden as well as site leader for its plant in Strängnäs.

The site opened in 2009 to produce the active ingredients for growth hormone Genotropin (somatropin) and the acromegaly treatment Somavert (pegvisomant).

Gjellan spent nine years at Pfizer in total, during which time she received the John Mitchell Quality Award for quality in manufacturing in 2006 and the Swedish Change Management Award for the best Change Management Project in 2013.

Her previous experience includes a 16-year period at AstraZeneca where she worked across drug discovery, research and manufacturing.

Geoffrey McDonough, president and CEO at Sobi, said he was “delighted” to welcome Gjellan to the company.

"Kirsti will continue to build on the legacy of our biologics manufacturing organisation, and to prepare us for our future products for patients with rare diseases.

Gjellan will complete her move to Sobi in September this year when current senior VP manufacturing operations Lena Nyström is due to retire.

28th May 2014

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....